He graduated from University of Warsaw, School of Management, with a major in Management and Marketing. In 2002, he completed the courses for applicants for supervisory board members in the State Treasury companies and "Management 2004", the annual programme for management skills development under the aegis of Harvard Business School Publishing and Canadian International Management Institute. Since December 2007, he has been advising the President of PKO BP S.A. on issues concerning capital group restructuring. In 2002 - 2007 as the President of the Management Board of Ciech Polfa Sp. z o.o., included in the Ciech Chemical Group, he successfully led the company's restructuring and transformed it into a modern distribution and commercial company. It has been awarded with the title of "Polish Outstanding Exporter" in the competition organised by the Rynki Zagraniczne magazine under the honorary patronage of Prime Minister of the Republic of Poland. In the meantime, Mr. Marcin Dobrzański was honoured with the Silver Cross of Merit handed by the President of the Republic of Poland. In 2005 - 2007, he was the Chair of the Supervisory Board of Polcommerce Kft. (Hungary), the partner company of Ciech SA. In 2000 - 2002, he was the head of a project carried out in Lek POLSKA Sp. z o.o., responsible for managing the acquisition of Zakład Farmaceutyczny “ARGON” SA in Łódź. He also conducted the world's second-largest acquisition of LEK d.d. the international pharmaceutical concern (the Novartis Group today). In 1997, he was the Supervisory Board member of Soda Mątwy SA (the Ciech Chemical Group). In 1996 - 1999, he was the Owner's Supervision expert in Ciech SA.
Marcin Dobrzański is not engaged in any competitive activity against Ciech SA. He is not any shareholder of a competitive (civil law) partnership, is not a member of a body of a capital company of any other legal person competitive against the Company. His name is not in the Register of Insolvent Debtors, which is kept according to the Act on the National Court Register.